Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 20065166)

1.

Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model.

Lenk K, Schur R, Linke A, Erbs S, Matsumoto Y, Adams V, Schuler G.

Eur J Heart Fail. 2009 Apr;11(4):342-8. doi: 10.1093/eurjhf/hfp020. Epub 2009 Feb 13.

PMID:
19218333
2.

Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.

Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, Reed JM, Madden MC, Mehan RS.

Am J Physiol Endocrinol Metab. 2008 May;294(5):E918-27. doi: 10.1152/ajpendo.00798.2007. Epub 2008 Mar 11.

3.

Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2008 Jan 29;117(4):e25-146. Epub 2007 Dec 17. No abstract available. Erratum in: Circulation. 2010 Jul 6;122(1):e10. Kissela, Bret [corrected to Kissela, Brett].

4.

Muscle growth after postdevelopmental myostatin gene knockout.

Welle S, Bhatt K, Pinkert CA, Tawil R, Thornton CA.

Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E985-91. Epub 2006 Dec 5.

5.

Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.

von Haehling S, Doehner W, Anker SD.

Cardiovasc Res. 2007 Jan 15;73(2):298-309. Epub 2006 Sep 1. Review.

6.

Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure.

Shyu KG, Lu MJ, Wang BW, Sun HY, Chang H.

Eur J Clin Invest. 2006 Oct;36(10):713-9.

PMID:
16968467
7.

Myostatin regulates cardiomyocyte growth through modulation of Akt signaling.

Morissette MR, Cook SA, Foo S, McKoy G, Ashida N, Novikov M, Scherrer-Crosbie M, Li L, Matsui T, Brooks G, Rosenzweig A.

Circ Res. 2006 Jul 7;99(1):15-24. Epub 2006 Jun 8.

8.

Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy.

Parsons SA, Millay DP, Sargent MA, McNally EM, Molkentin JD.

Am J Pathol. 2006 Jun;168(6):1975-85.

9.

Myofibrillar protein synthesis in myostatin-deficient mice.

Welle S, Bhatt K, Pinkert CA.

Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E409-15. Epub 2005 Oct 11.

10.

Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes.

Shyu KG, Ko WH, Yang WS, Wang BW, Kuan P.

Cardiovasc Res. 2005 Dec 1;68(3):405-14. Epub 2005 Aug 25.

11.

Muscle wasting in cardiac cachexia.

Strassburg S, Springer J, Anker SD.

Int J Biochem Cell Biol. 2005 Oct;37(10):1938-47. Review.

PMID:
15927519
12.

Cardiac cachexia.

Anker SD, Steinborn W, Strassburg S.

Ann Med. 2004;36(7):518-29. Review.

PMID:
15513302
13.

Regulation of muscle mass by myostatin.

Lee SJ.

Annu Rev Cell Dev Biol. 2004;20:61-86. Review.

PMID:
15473835
14.

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD.

Circ Res. 2004 Jan 9;94(1):110-8. Epub 2003 Dec 1.

15.

Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin.

Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hogue A, Fielder TJ, Gonzalez-Cadavid NF.

Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E876-88. Epub 2003 Jun 24.

16.

Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene.

Grobet L, Pirottin D, Farnir F, Poncelet D, Royo LJ, Brouwers B, Christians E, Desmecht D, Coignoul F, Kahn R, Georges M.

Genesis. 2003 Apr;35(4):227-38.

PMID:
12717734
17.

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S.

Lancet. 2003 Mar 29;361(9363):1077-83.

PMID:
12672310
18.

Functional improvement of dystrophic muscle by myostatin blockade.

Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS.

Nature. 2002 Nov 28;420(6914):418-21.

PMID:
12459784
19.

Induction of cachexia in mice by systemically administered myostatin.

Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ.

Science. 2002 May 24;296(5572):1486-8.

20.

Transcriptional effects of chronic Akt activation in the heart.

Cook SA, Matsui T, Li L, Rosenzweig A.

J Biol Chem. 2002 Jun 21;277(25):22528-33. Epub 2002 Apr 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk